Opthea Appoints Sujal Shah to the Board of Directors

03.04.2024 - Former CymaBay Therapeutics CEO brings extensive leadership experience to his role as a Non-Executive Director and Audit and Risk Committee ChairMELBOURNE, Australia and PRINCETON, N.J., April 03, 2024 (GLOBE NEWSWIRE) - Opthea Limited ... Seite 1

Related Keywords

Jeremy Levin ,Sujal Shah ,Dan Spiegelman ,Risk Committee Chairman ,Gilead Sciences ,Chief Executive Officer ,Cymabay Therapeutics ,Opthea Board ,Executive Director ,Risk Committee ,